H Laufen

1.9k total citations
76 papers, 1.5k citations indexed

About

H Laufen is a scholar working on Epidemiology, Pharmacology and Infectious Diseases. According to data from OpenAlex, H Laufen has authored 76 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 24 papers in Pharmacology and 18 papers in Infectious Diseases. Recurrent topics in H Laufen's work include Antibiotics Pharmacokinetics and Efficacy (20 papers), Antifungal resistance and susceptibility (14 papers) and Nail Diseases and Treatments (9 papers). H Laufen is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (20 papers), Antifungal resistance and susceptibility (14 papers) and Nail Diseases and Treatments (9 papers). H Laufen collaborates with scholars based in Germany, United States and United Kingdom. H Laufen's co-authors include A Wildfeuer, Till Zimmermann, R A Yeates, Jan Faergemann, G Pfaff, K. Riedel, H. H. Kornhuber, E. Mauch, Hilmar Krapf and Torsten Zimmermann and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Molecular Pharmacology and Journal of Pharmaceutical Sciences.

In The Last Decade

H Laufen

75 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Laufen Germany 22 470 365 325 186 176 76 1.5k
Elaine Radwanski United States 21 421 0.9× 369 1.0× 299 0.9× 263 1.4× 160 0.9× 62 1.8k
John G. Gambertoglio United States 31 648 1.4× 565 1.5× 572 1.8× 230 1.2× 210 1.2× 91 2.4k
Olivier Petitjean France 22 450 1.0× 246 0.7× 667 2.1× 137 0.7× 90 0.5× 89 1.6k
E Singlas France 23 294 0.6× 355 1.0× 310 1.0× 235 1.3× 198 1.1× 86 1.4k
A Wildfeuer Germany 21 551 1.2× 458 1.3× 366 1.1× 151 0.8× 114 0.6× 108 1.6k
P Periti Italy 21 505 1.1× 216 0.6× 450 1.4× 223 1.2× 164 0.9× 107 1.9k
Mack R. Holdiness United States 19 273 0.6× 274 0.8× 158 0.5× 87 0.5× 94 0.5× 53 1.3k
Karen I. Plaisance United States 17 239 0.5× 220 0.6× 434 1.3× 132 0.7× 67 0.4× 30 1.2k
Barry Dvorchik United States 20 230 0.5× 506 1.4× 520 1.6× 193 1.0× 262 1.5× 47 1.7k
James Longstreth United States 23 367 0.8× 242 0.7× 601 1.8× 324 1.7× 257 1.5× 40 2.2k

Countries citing papers authored by H Laufen

Since Specialization
Citations

This map shows the geographic impact of H Laufen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Laufen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Laufen more than expected).

Fields of papers citing papers by H Laufen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Laufen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Laufen. The network helps show where H Laufen may publish in the future.

Co-authorship network of co-authors of H Laufen

This figure shows the co-authorship network connecting the top 25 collaborators of H Laufen. A scholar is included among the top collaborators of H Laufen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Laufen. H Laufen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zimmermann, Till, et al.. (2001). Accumulation of fluconazole in sebum. International Journal of Clinical Pharmacology and Therapeutics. 39(9). 389–394. 5 indexed citations
2.
Zimmermann, Torsten, et al.. (1999). The Pharmacokinetics of Extended‐Release Formulations of Calcium Antagonists and of Amlodipine in Subjects with Different Gastrointestinal Transit Times. The Journal of Clinical Pharmacology. 39(10). 1021–1031. 25 indexed citations
3.
Laufen, H, et al.. (1999). Determination of azithromycin in gastric biopsy samples.. PubMed. 37(7). 361–4. 13 indexed citations
4.
Nichterlein, Thomas, et al.. (1998). Reduced intracellular activity of antibiotics against Listeria monocytogenes in multidrug resistant cells. International Journal of Antimicrobial Agents. 10(2). 119–125. 21 indexed citations
5.
Wildfeuer, A, H Laufen, R A Yeates, & Till Zimmermann. (1996). A new pharmaceutical concept for the treatment of oropharyngeal and oesophageal candidosis with fluconazole. Mycoses. 39(9-10). 357–360. 4 indexed citations
6.
Wildfeuer, A, H Laufen, A. Schmalreck, R A Yeates, & Till Zimmermann. (1996). Fluconazol: Vergleich von Pharmakokinetik, Therapie und Empfindlichkeit der Sproßpilze in vitro. Mycoses. 39(s2). 51–57. 5 indexed citations
7.
Faergemann, Jan, et al.. (1995). Intracutaneous transport of orally administered fluconazole to the stratum corneum.. Acta Dermato Venereologica. 75(5). 361–363. 13 indexed citations
8.
Zimmermann, Till, R A Yeates, H Laufen, G Pfaff, & A Wildfeuer. (1994). Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole. European Journal of Clinical Pharmacology. 46(2). 147–50. 140 indexed citations
9.
Laufen, H, et al.. (1994). Enantioselective disposition of oral amlodipine in healthy volunteers. Chirality. 6(7). 531–536. 19 indexed citations
10.
Riedel, K., et al.. (1994). Enantioselective gas chromatographic assay with electron-capture detection for amlodipine in biological samples. Journal of Chromatography B Biomedical Sciences and Applications. 655(2). 225–233. 40 indexed citations
11.
Wildfeuer, A, et al.. (1993). Comparison of the pharmacokinetics of three-day and five-day regimens of azithromycin in plasma and urine. Journal of Antimicrobial Chemotherapy. 31(suppl E). 51–56. 28 indexed citations
12.
Faergemann, Jan & H Laufen. (1993). Levels of fluconazole in serum, stratum corneum, epidermis-dermis (without stratum corneum) and eccrine sweat. Clinical and Experimental Dermatology. 18(2). 102–106. 80 indexed citations
13.
Mauch, E., et al.. (1992). Treatment of multiple sclerosis with mitoxantrone. European Archives of Psychiatry and Clinical Neuroscience. 242(2-3). 96–102. 54 indexed citations
14.
Mauch, E., et al.. (1989). Effective treatment of chronically progressive multiple sclerosis with low-dose cyclophosphamide with minor side-effects. European Archives of Psychiatry and Clinical Neuroscience. 238(3). 115–117. 6 indexed citations
15.
Laufen, H & A Wildfeuer. (1989). Kinetics of the uptake of antimicrobial agents by human polymorphonuclear leucocytes.. PubMed. 39(2). 233–5. 13 indexed citations
16.
Laufen, H, et al.. (1987). [The pharmacology and pharmacokinetics of glycerol-2-nitrate].. PubMed. 37(6). 692–8. 1 indexed citations
17.
Laufen, H, et al.. (1986). [Hypotensive, antianginal action and pharmacokinetics of glyceryl-1-nitrate in rats and dogs].. PubMed. 36(11). 1577–82. 3 indexed citations
18.
Yeates, R A, et al.. (1985). The reaction between organic nitrates and sulfhydryl compounds. A possible model system for the activation of organic nitrates.. Molecular Pharmacology. 28(6). 555–559. 46 indexed citations
19.
Laufen, H, et al.. (1984). The effect of food on the oral absorption of isosorbide‐5‐mononitrate.. British Journal of Clinical Pharmacology. 18(6). 967–968. 5 indexed citations
20.
Laufen, H, et al.. (1977). [On the pharmacokinetics of vincamine after i.v. and oral application to the dog (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 27(6a). 1255–64. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026